While GM-CSF holds promise in various gynecological applications, its safety profile is a critical aspect to consider. Clinical trials have demonstrated that GM-CSF is generally well-tolerated, but potential side effects include fever, fatigue, and injection site reactions. Long-term safety data are still being gathered, and it is essential for patients to be closely monitored during treatment.
